Advertisement

Topics

Companies Related to "Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer" [Most Relevant Company Matches] RSS

08:35 EST 17th November 2018 | BioPortfolio

Here are the most relevant search results for "Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Role Dutasteride Patients Undergoing Mapping Biopsy Early Stage" Companies 1–25 of 6,000+

Relevant

Precision Biopsy, LLC

Precision Biopsy, LLC is a privately-held startup company formed by Allied Minds, Inc. in cooperation with the University of Colorado to commercialize a revolutionary optical biopsy technology designed to improve the accuracy and reliability of prostate biopsies and the diagnosis of prostate cancer. www.precisionbiopsy.com


Ischemix, Inc.

Ischemix is a privately-held, clinical-stage pharmaceutical company developing novel cytoprotective compounds for the prevention and treatment of serious diseases and conditions. The initial focus of the Company is the prevention of acute kidney injury and cardiac injury in patients undergoing cardiac catheterization procedures. Ischemix’ lead product...

OncoWell, LLC

OncoWell, LLC, headquartered in New York, NY, provides complementary products and resources to patients undergoing cancer treatment. The company’s first offering, OncoWellCE, is a concentrated enzyme product to support patient wellness while undergoing chemotherapy or radiation therapy. OncoWell, LLC was founded in 2012 by James Nicholls, Peter Jenkin...


Propel Technology

PROPEL is a group of programs aimed at increasing the number and success rate of early-stage life sciences companies in Illinois. PROPEL helps guide the development of formation-stage and early-stage life sciences companies by providing entrepreneurs with access to specialized resources and expertise to prepare them for early-stage funding. PROPEL is a Cen...

Clinical Genomics Pty Ltd

Clinical Genomics is dedicated to improving patient outcomes through early detection of colorectal cancer. Clinical Genomics products span the full spectrum of colorectal cancer testing, lnSure® ONE™, a one sample fecal immunochemical test (FIT) for healthy adults to detect lower GI bleeding, and COLVERA®, a proprietary liquid biopsy blood test ...

Madrona Venture Group

Madrona (www.madrona.com) has been investing in early-stage technology companies in the Pacific Northwest since 1995 and has been privileged to play a role in some of the region's most successful technology ventures. The firm invests predominately in seed and Series A rounds across the information technology spectrum, including consumer Internet, commercia...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientis...

CheckedUp

CheckedUp extends the doctor-patient relationship beyond office walls. This proprietary, educational platform facilitates and enhances communication between doctors and patients at each stage in the care process. CheckedUp empowers patients to play an active role in their care by providing them with customized content from their healthcare provider (HCP) o...

AirXpanders, Inc.

Founded in 2005, AirXpanders, Inc. (www.airxpanders.com) designs, manufactures and markets innovative medical devices to improve breast reconstruction. The Company’s AeroForm Tissue Expander System, is used in patients undergoing two-stage breast reconstruction following mastectomy. Headquartered in San Jose, California, AirXpanders’ vision is to...

Toucan Capital Corp.

Toucan Capital Fund II, L.P. is a $120 million venture capital fund (SBIC) focused on seed and early-stage life science and advanced technology investments. Toucan Capital Corp. launched its first fund in 1997 and began investing its current fund in August of 2001. Toucan invests nationwide and is one of the largest and most active venture capital funds in seed and early-stage life science. Toucan...

SLIL Biomedical

SLIL Biomedical Corp. is an early-stage drug discovery company, focused on developing new treatments for cancer and other diseases. SLIL has patented technology and a pipeline of potential drugs, the first of which is expected to enter a human clinical trial for cancer in early 2002.SLIL has a strong board and well-qualified management. The Company also has outstanding scientific resources, led by...

Grid Therapeutics, LLC

Grid Therapeutics is a biotech company based on the innovative platform for discovering and isolating human derived antibodies. Dr Edward F. Patz, Jr, is the co-founder and CEO of Grid, located in Durham, North Carolina. The lead antibody was discovered in exceptional outcome early stage lung cancer patients who did not progress to develop metastasis. ...

Devicor® Medical Products, Inc.

Devicor Medical Products, headquartered in Cincinnati, Ohio, has more than 400 employees around the world. As the global market leader, Devicor is committed to advancing technology to help clinicians accurately diagnose breast disease, such as breast cancer, through minimally invasive procedures. Devicor’s product portfolio includes the world-renowned...

HST Global, Inc.

HST Global, Inc. is an Integrated Biotechnology Health and Wellness company that is developing and or acquiring a network of Wellness Centers worldwide that are primarily focused on the immunotherapy and alternative treatment of late stage cancer. In addition, the company intends to acquire innovative products for the treatment of late stage cancer. In thi...

Clairus Technologies Incorporated

Clairus has three essential teams working in concert throughout the different stages of the commercialization process: the science team, business team and marketing team. The objective of the teams is to select, develop and market technologies that fit within the Clairus niche markets: early stage therapeutics, early stage diagnostics, and platform research tools.

Allied Minds, Inc.

Allied Minds is a seed investment company creating partnerships with select universities to fund corporate spin-offs resulting from successful early stage technology research. By providing corporate development support as well as funding, Allied Minds aims to guide early stage companies to commercial success, thereby generating value for all stakeholders. For more information, logon to www.allie...

Mitomics

Mitomics is the world leader in the research and development of mitochondrial DNA (mtDNA)-based biomarkers – a new and innovative approach to the detection of cancer and other disease states. Leveraging its unparalleled insights into the role of mitochondria in cancer, the company is developing an extensive and proprietary portfolio of molecular tests...

Salix Pharmaceuticals

Salix Pharmaceuticals is dedicated to being the leading specialty pharmaceutical company providing products to gastroenterologists and their patients. In-license selective late-stage/marketed products Our "search and development" efforts are designed to identify and acquire late-stage and/or marketed proprietary pharmaceutical products for the treatment of gastrointestinal disease that have an...

MTI

MTI is a leading UK venture capital firm, providing risk capital and management resources to early stage high technology companies, normally ranging up to £5 million.MTI, founded in 1983 by Dr Paul Castle, has established itself as one of Europe’s principal venture capital fund managers. The firm has provided equity investment, advice and support to over 60 early-stage and start-up techn...

Kepivance™ (palifermin)

Kepivance™ (palifermin) is indicated to decrease the incidence and duration of severe oral mucositis (mouth sores) in patients withhematologic (blood) cancers undergoing high-dose chemotherapy, with or without radiation, followed by bone marrow transplant. The safety and efficacy of Kepivance™ have not been established in patients with nonhematologic malignancies.

Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast b...

ArthroCAD, Inc.

ArthroCAD is a medical device company focused on developing solutions to improve surgical outcomes for patients undergoing joint replacement procedures.

Xillix Technologies Corp

Xillix, based in British Columbia, Canada, focuses on the research, development and commercialization of medical imaging technologies which aid in the early detection and localization of cancer. Detecting cancer early can often mean the difference between life and death. Since its inception Xillix has developed innovative fluorescence endoscopy systems which allow physicians to see very small, ear...

Strathclyde Institute for Drug Research

SIDR promotes and supports innovative interdisciplinary drug research in the areas of drugs, agrochemicals and natural products, provides industry with early stage opportunities in drug discovery, and offers Strathclyde's expertise in drug research to companies seeking specialist assistance.This website provides information about early stage drug discovery opportunities, research expertise and fac...

Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those ...


More From BioPortfolio on "Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks